Loading company…
New York-based Progenics Pharmaceuticals/Lantheus Medical Imaging is a biopharmaceutical company developing cancer medicines.
Founded in 1988 and based in New York, US, Progenics Pharmaceuticals, Inc./Lantheus Medical Imaging, Inc. operates as a biopharmaceutical company that develops medicines for the treatment of cancer. Its listed stage is Series B.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Progenics Pharmaceuticals, Inc./Lantheus Medical Imaging, Inc.? This is my company